Skip to content

Musculoskeletal Changes After Physiotherapeutic Intervention in Podiatric Subjects

Musculoskeletal Changes Induced by Physiotherapeutic Intervention, and Their Impact on the Induction of Diabetic Foot Syndrome and Psychosocial Status in Type 2 Diabetes Mellitus

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04257409
Acronym
BIONEDIAN
Enrollment
80
Registered
2020-02-06
Start date
2019-01-01
Completion date
2021-01-01
Last updated
2020-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of Diabetic Foot

Keywords

diabetic foot, biomechanics, quality of life, prevention

Brief summary

The recurrence of diabetic foot ulcers (DFU) is a key problem in podiatric care. It is very often given by biomechanical abnormalities frequently present in those patients. The aim of our randomized controlled study is to find possible changes as of plantar pressures as of biomechanics of the ankle and small joints in patients with type 2 diabetes mellitus with different degrees of neuropathy. During this project, investigators will examine the possible impact of 12-week lasting intervention program on the distribution of plantar pressures, joint mobility and muscle strength of lower limbs. The incidence of ulcerations / reulcerations and changes of psychosocial characteristics will be evaluated during the study period. Approximately 60 patients with Type 2 diabetes mellitus will be included into the study. These patients will be randomized into 3 study groups - patients with type 2 DM with mild form of peripheral sensory neuropathy (20 subjects), patient with severe peripheral neuropathy (20 subjects) and those with diabetic foot syndrome, without active lesion (20 subjects). All patients will undergo 12 week lasting active intervention program consisting of recommendations by a physiotherapist focusing on the improvement of physical fitness, muscle strength and foot joint improvement. Control group will be consisted of 20 patients with healed diabetic foot. The outcomes of this project will try to objectively verify in the randomized controlled trial the impact of exercise on lower limb biomechanics, mobility, self-sufficiency, quality of life in patients with type 2 diabetes mellitus at risk or already developed diabetic foot syndrome.

Interventions

OTHERPhysical intervention by exercise

12 week lasting exercise intervention

Sponsors

Vladimíra Fejfarová, MD, PhD
CollaboratorUNKNOWN
prof. Ing. Václav Bunc, CSc
CollaboratorUNKNOWN
Mgr. Eliška Vrátná
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

randomization of diabetic patients with healed diabetic foot according the randomization scheme

Intervention model description

60 patients with Type 2 diabetes mellitus. These patients will be randomized into 3 study groups - patients with type 2 DM with mild form of peripheral sensory neuropathy (20 subjects), patient with severe peripheral neuropathy (20 subjects) and those with diabetic foot syndrome, without active lesion (20 subjects). All patients will undergo 12 week lasting active intervention program consisting of recommendations by a physiotherapist focusing on the improvement of physical fitness, muscle strength and foot joint improvement. Control group will be consisted of 20 patients with healed diabetic foot.

Eligibility

Sex/Gender
ALL
Age
30 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Type 2 diabetes mellitus * sensoric neuropathy (mild - based on VPV 15-30 V or EMG results, severe - based on VPT above 50 V or EMG results) * diabetic foot with healed diabetic foot ulcers, inactive Charcot foot

Exclusion criteria

* impossibility to exercise * amaurosis * non-compliance * critical limb ischemia * active ulcer, surgical wound * active Charcot foot * active carcinoma * recent stroke (last 8 weeks) * recent myocardial infarction (last 8 weeks) * recent PTA, PCI, bypass (last 8 weeks) * myopathy * rheumatoid arthritis * cox-, gonartrosis of 3rd -4th grade.

Design outcomes

Primary

MeasureTime frameDescription
Biomechanics- plantar pressureschanges after 12 weeks, 24 weeksplantar pressures will be evaluated by pedobarograph (in Newtons)
Biomechanics- biomechanics of the anklechanges after 12 weeks, 24 weeksbiomechanics of the ankle will be assessed by goniometry in angles
Biomechanics- changes of foot joint angleschanges after 12 weeks, 24 weekschanges of foot joint agles will be evaluated by measurement of X-Rays bones angles - calcaneal pitch, talar-1st metatarsal angle and lateral Talocalcaneal angle
Fitness - physical activitychanges after 12 weeks, 24 weeksThe amount of physical activity will be assessed by IPAQ questioners
Fitness - muscle strengthchanges after 12 weeks, 24 weeksMuscle strength will be measured by dynamometry in Newtons
Fitness - senior fitnesschanges after 12 weeks, 24 weeksfitness will be assessed by seniorfittest containing 2 minutes step test (steps/2 min) and test of sitting (sits/30 seconds)

Secondary

MeasureTime frameDescription
ulceration/reulcerationchanges after 12 weeks, 24 weeksdetection of the incidence of ulceration/reulceration
Metabolism - myokineschanges after 12 weeks, 24 weeksPatients will be checked for changes in selected cytokines nad myokines (IL-4,6,7,8,15 in pg/ml, myostatin in pg/ml, irisin in ng/ml, FGF-21 in pg/ml)
Psychosocial changes - quality of lifechanges after 12 weeks, 24 weeksQuality of life will be evaluated by WHO-QoL Bref test (4 domains - high values mean bettr findings
Psychosocial changes - depressionchanges after 12 weeks, 24 weeksDepression status will be asessed by Geriatric Depression Scale (GDS) scale - minimum 0, maximum 30 points (higher then 9 points- mild form of depression, higher then 20 - severe depression
Psychosocial changes - stress readaptationchanges after 12 weeks, 24 weeksAdaptation to stress will be detected by Stress Readaption Scale (0-400 points) - points higher then 150 - higher risk of worse stress readaptation and therefore higher risk of somatisation
Metabolism - glucose controlchanges after 12 weeks, 24 weeksInvestigators will be loked for metabolic changes in diabetes control (HbA1c in mmol/mol, glycemia in mmol/l)
Metabolism - lipid profilechanges after 12 weeks, 24 weeksThe authors will control lipid profiles (Total-, HDL-, LDL-cholesterol in umol/l)

Countries

Czechia

Contacts

Primary ContactEliška Vrátná, Mgr.
vratnae@gmail.com+420774549214
Backup ContactVladimíra Fejfarová, MD, PhD
vlfe@medicon.cz+420603877381

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026